Tumor marker

A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers (measure progression or response to therapy). They can be found in bodily fluids or tissue. Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response and monitor therapy.

Tumor markers can be molecules that are produced in higher amounts by cancer cells than normal cells, but can also be produced by other cells from a reaction with the cancer.

The markers can't be used to give patients a diagnosis but can be compared with the result of other tests like biopsy or imaging.

Classification

Tumor markers can be proteins, carbohydrates, receptors and gene products. Proteins include hormones and enzymes. To detect enzyme tumor markers enzyme activity is measured. They were previously widely used, but they have largely been replaced by oncofetal antigens and monoclonal antibodies, due to disadvantages such as most of them lacking organ specificity. Carbohydrates consist of antigens on and/or secreted from tumor cells, these are either high-molecular weight mucins or blood group antigens. Receptors are used to determine prognosis and measure how the patient responds to treatment, while genes or gene products can be analyzed to identify mutations in the genome or altered gene expression.[citation needed]

Uses

Tumor markers may be used for the following purposes:

Techniques

Tumor markers can be determined in serum or rarely in urine or other body fluids, often by immunoassay, but other techniques such as enzyme activity determination are sometimes used. Assaying tumor markers were significantly improved after the creation of ELISA and RIA techniques and the advancement of monoclonal antibodies in the 1960s and 1970s.

For many assays, different assay techniques are available. It is important that the same assay is used, as the results from different assays are generally not comparable. For example, mutations of the p53 gene can be detected through immunohistochemical polymorphism screening of DNA, sequence analysis of DNA, or by single-strand conformational polymorphism screening of DNA. Each assay may give different results of the clinical value of the p53 mutations as a prognostic factor.

Interlaboratory proficiency testing for tumor marker tests, and for clinical tests more generally, is routine in Europe and an emerging field in the United States. New York state is prominent in advocating such research.

List of commonly used markers

Tumor markerAssociated tumor types
Alpha fetoprotein (AFP)germ cell tumor, hepatocellular carcinoma
CA15-3breast cancer
CA 27.29breast cancer
CA19-9Mainly pancreatic cancer, but also colorectal cancer and other types of gastrointestinal cancer.
CA-125Mainly ovarian cancer, but may also be elevated in for example endometrial cancer, fallopian tube cancer, lung cancer, breast cancer and gastrointestinal cancer.
Calcitoninmedullary thyroid carcinoma
Calretininmesothelioma, sex cord-gonadal stromal tumor, adrenocortical carcinoma, synovial sarcoma
Carcinoembryonic antigen (CEA)gastrointestinal cancer, cervical cancer, lung cancer, ovarian cancer, breast cancer, urinary tract cancer
CD34hemangiopericytoma/solitary fibrous tumor, pleomorphic lipoma, gastrointestinal stromal tumor, dermatofibrosarcoma protuberans
CD99Ewing sarcoma, primitive neuroectodermal tumor, hemangiopericytoma/solitary fibrous tumor, synovial sarcoma, lymphoma, leukemia, sex cord-gonadal stromal tumor
CD117gastrointestinal stromal tumor, mastocytosis, seminoma
Chromograninneuroendocrine tumor
Chromosomes 3, 7, 17, and 9p21bladder cancer
CytokeratinMany types of carcinoma, some types of sarcoma
Desminsmooth muscle sarcoma, skeletal muscle sarcoma, endometrial stromal sarcoma
Epithelial membrane antigen (EMA)many types of carcinoma, meningioma, some types of sarcoma
Factor VIII; CD31, FL1, CD34vascular sarcoma
Glial fibrillary acidic protein (GFAP)glioma (astrocytoma, ependymoma)
Gross cystic disease fluid protein (GCDFP-15)breast cancer, ovarian cancer, salivary gland cancer
HMB-45melanoma, PEComa (for example angiomyolipoma), clear cell carcinoma, adrenocortical carcinoma
Human chorionic gonadotropin (hCG)gestational trophoblastic disease, germ cell tumor, choriocarcinoma
immunoglobulinlymphoma, leukemia
inhibinsex cord-gonadal stromal tumor, adrenocortical carcinoma, hemangioblastoma
keratin (various types)carcinoma, some types of sarcoma
lymphocyte marker (various types)lymphoma, leukemia
MART-1 (Melan-A)melanoma, steroid-producing tumors (adrenocortical carcinoma, gonadal tumor)
Myo D1rhabdomyosarcoma, small-blue-round-cell tumor
muscle-specific actin (MSA)myosarcoma (leiomyosarcoma, rhabdomyosarcoma)
neurofilamentneuroendocrine tumor; small-cell carcinoma of the lung
neuron-specific enolase (NSE)neuroendocrine tumor; small-cell carcinoma of the lung, breast cancer
placental alkaline phosphatase (PLAP)seminoma, dysgerminoma, embryonal carcinoma
prostate-specific antigen (PSA)prostate
S100 proteinmelanoma, sarcoma (neurosarcoma, lipoma, chondrosarcoma), astrocytoma, gastrointestinal stromal tumor, salivary gland cancer, some types of adenocarcinoma, histiocytic tumor (dendritic cell, macrophage)
smooth muscle actin (SMA)gastrointestinal stromal tumor, leiomyosarcoma, PEComa
synaptophysinneuroendocrine tumor
thymidine kinaselymphoma, leukemia, lung cancer, prostate cancer
thyroglobulin (Tg)post-operative marker of thyroid cancer (but not in medullary thyroid cancer)
thyroid transcription factor-1 (TTF-1)all types of thyroid cancer, lung cancer
Tumor M2-PKcolorectal cancer, Breast cancer, renal cell carcinoma lung cancer, pancreatic cancer, esophageal cancer, stomach cancer,cervical cancer, ovarian cancer,
vimentinsarcoma, renal cell carcinoma, endometrial cancer, lung carcinoma, lymphoma, leukemia, melanoma

Accuracy and specific use

The ideal tumor marker has the following characteristics:

An ideal tumor marker does not exist, and how they are clinically applied depends on the specific tumor marker. For example, tumor markers like Ki-67 can be used to choose form of treatment or in prognostics but are not useful to give a diagnosis, while other tumor markers have the opposite functionality. Therefore it's important to follow the guidelines of the specific tumor marker.

Tumor markers are mainly used in clinical medicine to support a diagnosis and monitor the state of malignancy or reocurrence of cancer.

See also